custom search
Reversed
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3753 Andreas Stihl AG & Co. KG 15178916 WIEKER 103 GUDRUN E. HUCKETT DRAUDT MACKAY-SMITH, SETH WENTWORTH
see also In re Eli Lilly & Co., 902 F.2d 943, 947–48 (Fed. Cir. 1990) (explaining that a review of cited precedent “shows the absence of detailed all-purpose criteria for applying the law of obviousness to every factual situation. No one precedent or rationale can be controlling in all possible areas of human creativity. . . . The obligation of the decision-maker is to apply the law consistently to the evidence for each new invention. All relevant facts must be considered, while recognizing that it is inappropriate to ‘squeez[e] new factual situations into pre-established pigeonholes.’”).
Eli Lilly, In re, 902 F.2d 943, 14 USPQ2d 1741 (Fed. Cir. 1990) 716.01(d) , 716.02(b) , 716.02(c) , 2142 , 2144 , 2144.08
Affirmed
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2456 May Patents Ltd. 15657163 JEFFERY 103 May Patents Ltd. c/o Dorit Shem-Tov KHAN, HASSAN ABDUR-RAHMAN
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3627 Mark Butsch et al. 14861000 McCARTNEY 103 WILEY HORTON MUTSCHLER, JOSEPH M
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3792 Michael GIROUARD et al. 15073580 GUIJT 103 GARVEY, SMITH & NEHRBASS, PATENT ATTORNEYS, L.L.C. SO, ELIZABETH K
SEARCH
PTAB.US: Decisions of PTAB Patent Trial and Appeal Board
Li & Cai
Showing posts with label eli lilly3. Show all posts
Showing posts with label eli lilly3. Show all posts
Friday, May 8, 2020
Monday, August 28, 2017
eli lilly3, yates
custom search
REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1632 Ex Parte Kee et al 13501998 - (D) NEWMAN 112(1) Bozicevic, Field & Francis LLP Stanford University Office of Technology Licensing WILSON, MICHAEL C
Tech Center 2100 Computer Architecture and Software
2175 Ex Parte Tsuda et al 13080835 - (D) THOMAS 102 KATTEN MUCHIN ROSENMAN LLP HO, RUAY L
Tech Center 2600 Communications
2611 Ex Parte FENNEY 13720318 - (D) BENNETT 103 Vorys, Sater, Seymour and Pease LLP (ImgTec) DU, HAIXIA
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2847 Ex Parte Kinzl et al 13557402 - (D) GUPTA 103 BROOKS KUSHMAN P.C. PAGHADAL, PARESH H
2883 Ex Parte Buff et al 13663975 - (D) OWENS 103 CORNING INCORPORATED RADKOWSKI, PETER
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3763 Ex Parte Kugler et al 13470854 - (D) BROWNE 103 SEAGER, TUFTE & WICKHEM, LLP VU, QUYNH-NHU HOANG
3766 Ex Parte Hill 13086519 - (D) TOWNSEND 103 Medtronic, Inc. (CRDM) GHAND, JENNIFER LEIGH-STEWAR
3766 Ex Parte Nguyen-Stella et al 12430304 - (D) SILVERMAN 103 Lowe Graham Jones Boston Scientific Neuromodulation Corp. BAYS, PAMELA M
In re Eli Lilly & Co., 902 F.2d 943, 947-A8 (Fed. Cir.1990) (“The uniform application of the law of ‘obviousness’ is essential to the commercial incentive that is the core of the patent system. The obligation of the decisionmaker is to apply the law consistently to the evidence for each new invention. All relevant facts must be considered, while recognizing that it is inappropriate to ‘squeez[e] new factual situations into preestablished pigeonholes.’”) (citing In re Yates, 663 F.2d 1054, 1056 n.4 (CCPA 1981))
Eli Lilly, In re, 902 F.2d 943, 14 USPQ2d 1741 (Fed. Cir. 1990) 716.01(d) , 716.02(b) , 716.02(c) , 2142 , 2144 , 2144.08
3777 Ex Parte OSTROVSKY et al 13608613 - (D) SCHNEIDER 103 Fay Kaplun & Marcin, LLP — BSC NGUYEN, HIEN NGOC
AFFIRMED-IN-PART
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3643 Ex Parte Spittle 13926114 - (D) PESLAK 103 103 BROOKS KUSHMAN P.C. NGUYEN, SON T
3667 Ex Parte Hannukainen et al 13449824 - (D) SHAH 112(2)/103 102/103 41.50 101 Ditthavong & Steiner, P.C. SWEENEY, BRIAN P
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3724 Ex Parte Weismantel et al 12521857 - (D) WIEDER 103 103 MARSHALL, GERSTEIN & BORUN LLP CHOI, STEPHEN
3738 Ex Parte Long 11904079 - (D) MAJORS 103 103 MAGINOT, MOORE & BECK, LLP PRESTON, REBECCA STRASZHEIM
3786 Ex Parte Halmann et al 14015252 - (D) FREDMAN 103 112(2)/102/103 MCANDREWS HELD & MALLOY, LTD BRUTUS, JOEL F
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1771 Ex Parte Wells et al 13552702 - (D) ROBERTSON 103 ExxonMobil Research & Engineering Company HINES, LATOSHAD
1784 Ex Parte Kojima et al 13752816 - (D) INGLESE 103 OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. WANG, XIAOBEI
1799 Ex Parte Maxik et al 14211663 - (D) ROSS 103 Widerman Malek, PL Biological Illumination, LLC SPAMER, DONALD R
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2854 Ex Parte Hoier et al 12089023 - (D) McGEE 103 SEAGER, TUFTE & WICKHEM, LLP OLAMIT, JUSTIN N
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Ex Parte Gordon et al 11465923 - (D) WIEDER 101 HOFFMAN WARNTOK T T C MILLER, ALAN S
3682 Ex Parte Kingsborough et al 11459733 - (D) MEYERS 103 101 CONLEY ROSE, P.C. BOVEJA, NAMRATA
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3715 Ex Parte Wong et al 13665806 - (D) WOODS 103 HONEYWELL/LKGlobal GEBREMICHAEL, BRUK A
3726 Ex Parte Rose 13492303 - (D) STAICOVICI 112(1)/103 Kinney & Lange, P.A. HOLLY, LEE A
3744 Ex Parte Donnat et al 13002217 - (D) CALVE 103 Cantor Colburn LLP - Carrier TEITELBAUM, DAVID J
3762 Ex Parte North 13640616 - (D) FREDMAN 112(2) 103 41.50 103 Haynes and Boone, LLP (46901) EVANISKO, GEORGE ROBERT
3768 Ex Parte Georgopoulos 13312332 - (D) NEW 101 112(6)/101/103 DICKE, BILLIG & CZAJA FERNANDEZ, KATHERINE L
3781 Ex Parte ORGELDINGER 12749713 - (D) OSINSKI 103 KEATING & BENNETT, LLP SCHOPPE, ZIMMERMANN , STOCKELER & ZINKLER ALLEN, JEFFREY R
REHEARING
DENIED
Tech Center 2600 Communications
2696 Ex Parte Davydov et al 12958326 - (R) HUME 103 Apple c/o MORRISON & FOERSTER LLP SF LANDIS, LISAS
REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1632 Ex Parte Kee et al 13501998 - (D) NEWMAN 112(1) Bozicevic, Field & Francis LLP Stanford University Office of Technology Licensing WILSON, MICHAEL C
Tech Center 2100 Computer Architecture and Software
2175 Ex Parte Tsuda et al 13080835 - (D) THOMAS 102 KATTEN MUCHIN ROSENMAN LLP HO, RUAY L
Tech Center 2600 Communications
2611 Ex Parte FENNEY 13720318 - (D) BENNETT 103 Vorys, Sater, Seymour and Pease LLP (ImgTec) DU, HAIXIA
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2847 Ex Parte Kinzl et al 13557402 - (D) GUPTA 103 BROOKS KUSHMAN P.C. PAGHADAL, PARESH H
2883 Ex Parte Buff et al 13663975 - (D) OWENS 103 CORNING INCORPORATED RADKOWSKI, PETER
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3763 Ex Parte Kugler et al 13470854 - (D) BROWNE 103 SEAGER, TUFTE & WICKHEM, LLP VU, QUYNH-NHU HOANG
3766 Ex Parte Hill 13086519 - (D) TOWNSEND 103 Medtronic, Inc. (CRDM) GHAND, JENNIFER LEIGH-STEWAR
3766 Ex Parte Nguyen-Stella et al 12430304 - (D) SILVERMAN 103 Lowe Graham Jones Boston Scientific Neuromodulation Corp. BAYS, PAMELA M
In re Eli Lilly & Co., 902 F.2d 943, 947-A8 (Fed. Cir.1990) (“The uniform application of the law of ‘obviousness’ is essential to the commercial incentive that is the core of the patent system. The obligation of the decisionmaker is to apply the law consistently to the evidence for each new invention. All relevant facts must be considered, while recognizing that it is inappropriate to ‘squeez[e] new factual situations into preestablished pigeonholes.’”) (citing In re Yates, 663 F.2d 1054, 1056 n.4 (CCPA 1981))
Eli Lilly, In re, 902 F.2d 943, 14 USPQ2d 1741 (Fed. Cir. 1990) 716.01(d) , 716.02(b) , 716.02(c) , 2142 , 2144 , 2144.08
3777 Ex Parte OSTROVSKY et al 13608613 - (D) SCHNEIDER 103 Fay Kaplun & Marcin, LLP — BSC NGUYEN, HIEN NGOC
AFFIRMED-IN-PART
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3643 Ex Parte Spittle 13926114 - (D) PESLAK 103 103 BROOKS KUSHMAN P.C. NGUYEN, SON T
3667 Ex Parte Hannukainen et al 13449824 - (D) SHAH 112(2)/103 102/103 41.50 101 Ditthavong & Steiner, P.C. SWEENEY, BRIAN P
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3724 Ex Parte Weismantel et al 12521857 - (D) WIEDER 103 103 MARSHALL, GERSTEIN & BORUN LLP CHOI, STEPHEN
3738 Ex Parte Long 11904079 - (D) MAJORS 103 103 MAGINOT, MOORE & BECK, LLP PRESTON, REBECCA STRASZHEIM
3786 Ex Parte Halmann et al 14015252 - (D) FREDMAN 103 112(2)/102/103 MCANDREWS HELD & MALLOY, LTD BRUTUS, JOEL F
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1771 Ex Parte Wells et al 13552702 - (D) ROBERTSON 103 ExxonMobil Research & Engineering Company HINES, LATOSHAD
1784 Ex Parte Kojima et al 13752816 - (D) INGLESE 103 OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. WANG, XIAOBEI
1799 Ex Parte Maxik et al 14211663 - (D) ROSS 103 Widerman Malek, PL Biological Illumination, LLC SPAMER, DONALD R
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2854 Ex Parte Hoier et al 12089023 - (D) McGEE 103 SEAGER, TUFTE & WICKHEM, LLP OLAMIT, JUSTIN N
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Ex Parte Gordon et al 11465923 - (D) WIEDER 101 HOFFMAN WARNTOK T T C MILLER, ALAN S
3682 Ex Parte Kingsborough et al 11459733 - (D) MEYERS 103 101 CONLEY ROSE, P.C. BOVEJA, NAMRATA
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3715 Ex Parte Wong et al 13665806 - (D) WOODS 103 HONEYWELL/LKGlobal GEBREMICHAEL, BRUK A
3726 Ex Parte Rose 13492303 - (D) STAICOVICI 112(1)/103 Kinney & Lange, P.A. HOLLY, LEE A
3744 Ex Parte Donnat et al 13002217 - (D) CALVE 103 Cantor Colburn LLP - Carrier TEITELBAUM, DAVID J
3762 Ex Parte North 13640616 - (D) FREDMAN 112(2) 103 41.50 103 Haynes and Boone, LLP (46901) EVANISKO, GEORGE ROBERT
3768 Ex Parte Georgopoulos 13312332 - (D) NEW 101 112(6)/101/103 DICKE, BILLIG & CZAJA FERNANDEZ, KATHERINE L
3781 Ex Parte ORGELDINGER 12749713 - (D) OSINSKI 103 KEATING & BENNETT, LLP SCHOPPE, ZIMMERMANN , STOCKELER & ZINKLER ALLEN, JEFFREY R
REHEARING
DENIED
Tech Center 2600 Communications
2696 Ex Parte Davydov et al 12958326 - (R) HUME 103 Apple c/o MORRISON & FOERSTER LLP SF LANDIS, LISAS
Labels:
eli lilly3
,
yates
Friday, June 21, 2013
eli lilly3, piasecki, rinehart
custom search
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1734 Ex Parte Mikulec et al 12209802 - (D) SMITH 103 KILPATRICK TOWNSEND & STOCKTON LLP LEE, REBECCA Y
1741 Ex Parte Hoess et al 10546241 - (D) HASTINGS 103 OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. MINSKEY, JACOB T
After a prima facie case of obviousness has been made and rebuttal evidence submitted, all the evidence must be considered anew. In re Eli Lilly & Co., 902 F. 2d 943, 945 (Fed. Cir. 1990) (citing In re Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788 (Fed.Cir.1984)): Piaseki at 745 F.2d at 1472 ("Prima facie obviousness is a legal conclusion, not a fact. Facts established by rebuttal evidence must be evaluated along with the facts on which the earlier conclusion was reached, not against the conclusion itself." (quoting In re Rinehart, 531 F.2d 1048, 1052, 189 USPQ 143, 147 (CCPA 1976)).
Eli Lilly, In re, 902 F.2d 943, 14 USPQ2d 1741 (Fed. Cir. 1990) 716.01(d), 716.02(b), 716.02(c), 2142, 2144, 2144.08
Piasecki, In re, 745 F.2d 1468, 223 USPQ 785 (Fed. Cir. 1984) 716.01(d), 2107.02, 2142, 2145
DONNER 8: 18, 20, 26, 27, 994, 996, 1008, 1010, 1063, 1064, 1321-25
HARMON 1: 239-41; 4: 151, 316, 369; 18: 60
Rinehart, In re, 531 F.2d 1048, 189 USPQ 143 (CCPA 1976) 2107.02, 2142, 2143.02, 2144.04
DONNER 8: 96, 1044, 1073
1771 Ex Parte Smith et al 12549579 - (D) DELMENDO 103 CARMODY & TORRANCE LLP OLADAPO, TAIWO
Tech Center 2600 Communications
2668 Ex Parte Torre-Bueno et al 10882661 - (D) BUSCH 112(2)/103 PATTERSON THUENTE PEDERSEN, P.A. TSAI, TSUNG YIN
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2811 Ex Parte Yamazaki et al 10199514 - (D) TURNER 101/112(2)/103 Robinson Intellectual Property Law Office, P.C. NADAV, ORI
2812 Ex Parte Kim et al 10988481 - (D) NAGUMO 103 GE Licensing POMPEY, RON EVERETT
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3636 Ex Parte Schurg et al 10587218 - (D) WEATHERLY 102/103 ROYLANCE, ABRAMS, BERDO & GOODMAN, L.L.P. GARRETT, ERIKA P
AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Fairbourn 11721564 - (D) OBERMANN 103 103 WOOD, HERRON & EVANS, LLP EMPIE, NATHAN H
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Neal et al 12257581 - (D) SMITH 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY c/o CPA Global EMPIE, NATHAN H
1712 Ex Parte Strock et al 11739823 - (D) PAK 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY c/o CPA Global HORNING, JOEL G
1735 Ex Parte Halken et al 12287482 - (D) SMITH 103 SIEMENS CORPORATION STONER, KILEY SHAWN
1758 Ex Parte Yang et al 11456887 - (D) PAK 103 General Motors Corporation c/o REISING ETHINGTON P.C. MERSHON, JAYNE L
1771 Ex Parte Habeeb et al 11527309 - (D) OBERMANN 103 37 C.F.R. § 41.50 (b) 103 ExxonMobil Research and Engineering Company GOLOBOY, JAMES C
1788 Ex Parte Keung 12190454 - (D) SMITH 103 EXXONMOBIL CHEMICAL COMPANY PATEL, RONAK C
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2427 Ex Parte Ostrowka 11163755 - (D) DIXON 103 MERCHANT & GOULD SCIENTIFIC ATLANTA, A CISCO COMPANY LANGHNOJA, KUNAL N
Tech Center 2600 Communications
2654 Ex Parte Hanna 09638245 - (D) JEFFERY 103 McDermott Will & Emery LEE, PING
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3721 Ex Parte Maslowski et al 11836608 - (D) CAPP 103 FITCH EVEN TABIN & FLANNERY, LLP DESAI, HEMANT
3782 Ex Parte BRUNSON et al 12184402 - (D) BROWNE 103 ZARLEY LAW FIRM P.L.C. LARSON, JUSTIN MATTHEW
REEXAMINATION
AFFIRMED
2747 Ex parte APPLE, INC., Appellant and Patent Owner 90011287 5946647 08/595,257 SIU 102 Apple Inc. c/o Novak Druce Connolly Bove + Quigg LLP STEELMAN, MARY J original EDOUARD, PATRICK NESTOR
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3671 THE TORO COMPANY Requester, Cross-Appellant, Respondent v. WRIGHT MANUFACTURING, INC. Patent Owner, Appellant, Respondent 95001742 6,935,093 10/186,680 SONG 103 NIXON & VANDERHYE, PC THIRD PARTY REQUESTER: James W. Miller JASTRZAB, JEFFREY R original FABIAN-KOVACS, ARPAD
3671 THE TORO COMPANY Requester, Cross-Appellant, Respondent v. WRIGHT MANUFACTURING, INC. Patent Owner, Appellant, Respondent 95001741 6,438,931 09/714,824 SONG 103 NIXON & VANDERHYE PC THIRD PARTY REQUESTER: James W. Miller JASTRZAB, JEFFREY R original FABIAN-KOVACS, ARPAD
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1734 Ex Parte Mikulec et al 12209802 - (D) SMITH 103 KILPATRICK TOWNSEND & STOCKTON LLP LEE, REBECCA Y
1741 Ex Parte Hoess et al 10546241 - (D) HASTINGS 103 OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. MINSKEY, JACOB T
After a prima facie case of obviousness has been made and rebuttal evidence submitted, all the evidence must be considered anew. In re Eli Lilly & Co., 902 F. 2d 943, 945 (Fed. Cir. 1990) (citing In re Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788 (Fed.Cir.1984)): Piaseki at 745 F.2d at 1472 ("Prima facie obviousness is a legal conclusion, not a fact. Facts established by rebuttal evidence must be evaluated along with the facts on which the earlier conclusion was reached, not against the conclusion itself." (quoting In re Rinehart, 531 F.2d 1048, 1052, 189 USPQ 143, 147 (CCPA 1976)).
Eli Lilly, In re, 902 F.2d 943, 14 USPQ2d 1741 (Fed. Cir. 1990) 716.01(d), 716.02(b), 716.02(c), 2142, 2144, 2144.08
Piasecki, In re, 745 F.2d 1468, 223 USPQ 785 (Fed. Cir. 1984) 716.01(d), 2107.02, 2142, 2145
DONNER 8: 18, 20, 26, 27, 994, 996, 1008, 1010, 1063, 1064, 1321-25
HARMON 1: 239-41; 4: 151, 316, 369; 18: 60
Rinehart, In re, 531 F.2d 1048, 189 USPQ 143 (CCPA 1976) 2107.02, 2142, 2143.02, 2144.04
DONNER 8: 96, 1044, 1073
1771 Ex Parte Smith et al 12549579 - (D) DELMENDO 103 CARMODY & TORRANCE LLP OLADAPO, TAIWO
Tech Center 2600 Communications
2668 Ex Parte Torre-Bueno et al 10882661 - (D) BUSCH 112(2)/103 PATTERSON THUENTE PEDERSEN, P.A. TSAI, TSUNG YIN
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2811 Ex Parte Yamazaki et al 10199514 - (D) TURNER 101/112(2)/103 Robinson Intellectual Property Law Office, P.C. NADAV, ORI
2812 Ex Parte Kim et al 10988481 - (D) NAGUMO 103 GE Licensing POMPEY, RON EVERETT
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3636 Ex Parte Schurg et al 10587218 - (D) WEATHERLY 102/103 ROYLANCE, ABRAMS, BERDO & GOODMAN, L.L.P. GARRETT, ERIKA P
AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Fairbourn 11721564 - (D) OBERMANN 103 103 WOOD, HERRON & EVANS, LLP EMPIE, NATHAN H
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Neal et al 12257581 - (D) SMITH 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY c/o CPA Global EMPIE, NATHAN H
1712 Ex Parte Strock et al 11739823 - (D) PAK 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY c/o CPA Global HORNING, JOEL G
1735 Ex Parte Halken et al 12287482 - (D) SMITH 103 SIEMENS CORPORATION STONER, KILEY SHAWN
1758 Ex Parte Yang et al 11456887 - (D) PAK 103 General Motors Corporation c/o REISING ETHINGTON P.C. MERSHON, JAYNE L
1771 Ex Parte Habeeb et al 11527309 - (D) OBERMANN 103 37 C.F.R. § 41.50 (b) 103 ExxonMobil Research and Engineering Company GOLOBOY, JAMES C
1788 Ex Parte Keung 12190454 - (D) SMITH 103 EXXONMOBIL CHEMICAL COMPANY PATEL, RONAK C
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2427 Ex Parte Ostrowka 11163755 - (D) DIXON 103 MERCHANT & GOULD SCIENTIFIC ATLANTA, A CISCO COMPANY LANGHNOJA, KUNAL N
Tech Center 2600 Communications
2654 Ex Parte Hanna 09638245 - (D) JEFFERY 103 McDermott Will & Emery LEE, PING
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3721 Ex Parte Maslowski et al 11836608 - (D) CAPP 103 FITCH EVEN TABIN & FLANNERY, LLP DESAI, HEMANT
3782 Ex Parte BRUNSON et al 12184402 - (D) BROWNE 103 ZARLEY LAW FIRM P.L.C. LARSON, JUSTIN MATTHEW
REEXAMINATION
AFFIRMED
2747 Ex parte APPLE, INC., Appellant and Patent Owner 90011287 5946647 08/595,257 SIU 102 Apple Inc. c/o Novak Druce Connolly Bove + Quigg LLP STEELMAN, MARY J original EDOUARD, PATRICK NESTOR
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3671 THE TORO COMPANY Requester, Cross-Appellant, Respondent v. WRIGHT MANUFACTURING, INC. Patent Owner, Appellant, Respondent 95001742 6,935,093 10/186,680 SONG 103 NIXON & VANDERHYE, PC THIRD PARTY REQUESTER: James W. Miller JASTRZAB, JEFFREY R original FABIAN-KOVACS, ARPAD
3671 THE TORO COMPANY Requester, Cross-Appellant, Respondent v. WRIGHT MANUFACTURING, INC. Patent Owner, Appellant, Respondent 95001741 6,438,931 09/714,824 SONG 103 NIXON & VANDERHYE PC THIRD PARTY REQUESTER: James W. Miller JASTRZAB, JEFFREY R original FABIAN-KOVACS, ARPAD
Labels:
eli lilly3
,
piasecki
,
rinehart
Subscribe to:
Posts
(
Atom
)